caffeic acid has been researched along with Diabetes Mellitus, Type 2 in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 5 (31.25) | 2.80 |
| Authors | Studies |
|---|---|
| Gregersen, S; Hermansen, K; Jeppesen, PB; Mellbye, FB | 1 |
| Guo, CL; Guo, SJ; Jiang, B; Li, N; Li, XQ; Shi, DY; Wang, LJ | 1 |
| Erukainure, OL; Ijomone, OM; Islam, MS; Salau, VF | 1 |
| Chukwuma, CI; Makhafola, TJ; Mashele, SS; Matowane, GR | 1 |
| Istyastono, EP; Mungkasi, S; Prasasty, VD; Riswanto, FDO; Waskitha, SSW; Yanuar, MRS; Yuniarti, N | 1 |
| Bohlmann, J; Irmisch, S; Jancsik, S; Madilao, LL; Yuen, MMS | 1 |
| Bian, Y; Huang, X; Liu, Y; Xu, J; Xue, M; Zhang, L; Zhou, J | 1 |
| Barre, DE; Mizier-Barre, KA | 1 |
| Deleanu, M; Niculescu, LS; Sanda, GM; Sima, AV; Stancu, CS; Toma, L | 1 |
| Adefegha, SA; Ademiluyi, AO; Agunloye, OM; Akinyemi, AJ; Oboh, G | 1 |
| Cassidy, A; Franke, AA; Hu, FB; Pan, A; Rimm, EB; Sun, Q; Townsend, MK; Tworoger, SS; van Dam, RM; Wedick, NM | 1 |
| Alfonso, H; Fujiwara, Y; Hiramatsu, N; Ishisaka, A; Lee, AH; Takechi, R; Tan, L'; Tanaka, A; Uemura, N | 1 |
| Bourdon, E; Roche, M; Rondeau, P; Tarnus, E | 1 |
| Chaiyasut, C; Jaikang, C; Kusirisin, W; Lailerd, N; Lerttrakarnnon, P; Srichairatanakool, S; Suttajit, M | 1 |
| Bidel, S; Carstensen, M; Erlund, I; Herder, C; Kempf, K; Koenig, W; Kolb, H; Kuha, S; Martin, S; Sundvall, J; Tuomilehto, J | 1 |
| Chen, H; Cheng, B; Gong, H; Huang, K; Huang, L; Jiao, L; Li, C; Liu, X; Ma, B; Yang, M; Zhang, X; Zheng, L | 1 |
2 review(s) available for caffeic acid and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Molecular Docking Simulation; Structure-Activity Relationship | 2018 |
The polypharmacy reduction potential of cinnamic acids and some related compounds in pre- and post-onset management of type 2 diabetes mellitus.
Topics: Acrolein; Animals; Caffeic Acids; Chlorogenic Acid; Cinnamates; Coumaric Acids; Diabetes Mellitus, Type 2; Dyslipidemias; Humans; Hyperglycemia; Hypertension; Inflammation; Obesity, Abdominal; Polypharmacy | 2020 |
1 trial(s) available for caffeic acid and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial.
Topics: Adiponectin; Adult; Anti-Inflammatory Agents; Apolipoproteins; Biomarkers; Blood Glucose; Caffeic Acids; Caffeine; Chlorogenic Acid; Cholesterol; Coffee; Diabetes Mellitus, Type 2; Dinoprost; Female; Humans; Inflammation; Interleukin-18; Lipids; Male; Middle Aged; Plant Preparations; Risk Factors; Single-Blind Method | 2010 |
13 other study(ies) available for caffeic acid and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Cafestol, a Bioactive Substance in Coffee, Stimulates Insulin Secretion and Increases Glucose Uptake in Muscle Cells: Studies in Vitro.
Topics: Alkaloids; Animals; Butylene Glycols; Caffeic Acids; Chlorogenic Acid; Coffee; Diabetes Mellitus, Type 2; Diterpenes; Glucose; Guinea Pigs; Humans; Insulin; Insulin Secretion; Insulin-Secreting Cells; Lignans; Muscle, Skeletal | 2015 |
Caffeic acid regulates glucose homeostasis and inhibits purinergic and cholinergic activities while abating oxidative stress and dyslipidaemia in fructose-streptozotocin-induced diabetic rats.
Topics: Acetylcholinesterase; Animals; Blood Glucose; Caffeic Acids; Cholesterol; Cholinergic Agents; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dyslipidemias; Fructose; Homeostasis; Hypoglycemic Agents; Male; Oxidative Stress; Plant Extracts; Rats; Rats, Sprague-Dawley; Streptozocin | 2022 |
The ameliorative effect of zinc acetate with caffeic acid in the animal model of type 2 diabetes.
Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Metformin; Rats; Rats, Sprague-Dawley; Zinc; Zinc Acetate | 2023 |
Caffeic Acid in Spent Coffee Grounds as a Dual Inhibitor for MMP-9 and DPP-4 Enzymes.
Topics: Coffee; Diabetes Mellitus, Type 2; Ethanol; Humans; Matrix Metalloproteinase 9; Plant Extracts | 2023 |
Biosynthesis of the anti-diabetic metabolite montbretin A: glucosylation of the central intermediate mini-MbA.
Topics: Caffeic Acids; Diabetes Mellitus, Type 2; Flavones; Flavonoids; Flavonols; Gene Expression Profiling; Gene Expression Regulation, Plant; Glucose; Glucosyltransferases; Glycosides; Glycosylation; Hypoglycemic Agents; Iridaceae; Metabolic Engineering; Nicotiana; Phylogeny; Plant Proteins; Plant Stems; Plants, Genetically Modified; Rhamnose; Secondary Metabolism; Synthetic Biology; Transcriptome; Trisaccharides; Xylose | 2019 |
Danggui Buxue decoction ameliorates lipid metabolic defects involved in the initiation of diabetic atherosclerosis; identification of active compounds.
Topics: Animals; Atherosclerosis; Caffeic Acids; Coumaric Acids; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Humans; Lipid Metabolism; Male; Rats; Rats, Wistar | 2020 |
Caffeic acid attenuates the inflammatory stress induced by glycated LDL in human endothelial cells by mechanisms involving inhibition of AGE-receptor, oxidative, and endoplasmic reticulum stress.
Topics: Antioxidants; C-Reactive Protein; Caffeic Acids; Diabetes Mellitus, Type 2; Endoplasmic Reticulum Stress; Endothelial Cells; Gene Expression Regulation; Glycation End Products, Advanced; Humans; Inflammation; Lipoproteins, LDL; Oxidation-Reduction; Oxidative Stress; Receptor for Advanced Glycation End Products; Receptors, CCR2; Vascular Cell Adhesion Molecule-1 | 2017 |
Caffeic and chlorogenic acids inhibit key enzymes linked to type 2 diabetes (in vitro): a comparative study.
Topics: alpha-Amylases; alpha-Glucosidases; Antioxidants; Caffeic Acids; Chlorogenic Acid; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Enzyme Inhibitors; Free Radical Scavengers; Hypoglycemic Agents; In Vitro Techniques; Inhibitory Concentration 50 | 2015 |
Urinary Excretion of Select Dietary Polyphenol Metabolites Is Associated with a Lower Risk of Type 2 Diabetes in Proximate but Not Remote Follow-Up in a Prospective Investigation in 2 Cohorts of US Women.
Topics: Adult; Aged; Aged, 80 and over; Caffeic Acids; Case-Control Studies; Catechin; Coumaric Acids; Diabetes Mellitus, Type 2; Female; Flavanones; Follow-Up Studies; Hesperidin; Humans; Hydroxybenzoates; Middle Aged; Nutrition Assessment; Polyphenols; Prospective Studies; Quercetin; Risk Factors; Surveys and Questionnaires | 2015 |
Plasma concentrations of coffee polyphenols and plasma biomarkers of diabetes risk in healthy Japanese women.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Caffeic Acids; Chlorogenic Acid; Coffee; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Middle Aged; Risk | 2016 |
Effects of nutritional antioxidants on AAPH- or AGEs-induced oxidative stress in human SW872 liposarcoma cells.
Topics: Adipocytes; Amidines; Animals; Antioxidants; Ascorbic Acid; Caffeic Acids; Cattle; Cell Line; Cell Proliferation; Cell Survival; Diabetes Mellitus, Type 2; Free Radicals; Glycation End Products, Advanced; Humans; Obesity; Oxidants; Oxidative Stress; Phytotherapy; Quercetin; Serum Albumin, Bovine; Superoxide Dismutase; Tocopherols; Up-Regulation | 2009 |
Antioxidative activity, polyphenolic content and anti-glycation effect of some Thai medicinal plants traditionally used in diabetic patients.
Topics: Antioxidants; Benzothiazoles; Caffeic Acids; Catechin; Diabetes Mellitus, Type 2; Flavonoids; Free Radicals; Gallic Acid; Glycation End Products, Advanced; Humans; Lipid Peroxidation; Medicine, Traditional; Molecular Structure; Oxidative Stress; Phenols; Plant Extracts; Plants, Medicinal; Polyphenols; Pyrogallol; Rutin; Sulfonic Acids; Tannins; Thailand; Thiobarbituric Acid Reactive Substances | 2009 |
Coffee components inhibit amyloid formation of human islet amyloid polypeptide in vitro: possible link between coffee consumption and diabetes mellitus.
Topics: Amino Acid Sequence; Amyloid; Caffeic Acids; Caffeine; Cell Line; Cell Survival; Chlorogenic Acid; Coffee; Diabetes Mellitus, Type 2; Humans; Islet Amyloid Polypeptide; Microscopy, Electron, Transmission; Molecular Sequence Data; Protein Folding; Protein Structure, Secondary | 2011 |